Roche drops $1.85B for GenMark's testing tech as pandemic, antibiotic resistance threats loom
Roche has only played a minor role in the hunt for Covid-19 drugs and vaccines. Instead, the Swiss giant made their influence in a field …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
